Ekso Bionics

Ekso Bionics develops advanced exoskeleton systems that augment human mobility, strength, and endurance across medical and industrial environments. For rehabilitation settings, the company offers the EksoNR and Ekso Indego product lines: FDA-cleared robotic exoskeletons used in gait training for individuals recovering from stroke, spinal cord injury, and acquired brain injury. These devices combine proprietary hardware with integrated sensors, adaptive control algorithms, and therapist-guided software that personalizes gait patterns and tracks patient progress. In industrial settings, Ekso’s upper-body support systems help reduce worker fatigue and repetitive-strain injuries in manufacturing, construction, and aerospace. Across both domains, Ekso is layering in new AI-enabled features, including real-time edge sensing, adaptive mobility algorithms, and early versions of interactive guidance tools like the Ekso Voice Agent.
Ekso’s commercial model is built around capital equipment sales supported by optional service and software contracts. Medical and industrial customers typically purchase exoskeletons outright as durable assets, with prices varying by device capability and clinical or industrial application. This CapEx approach reflects the regulatory and operational realities of medical robotics, where institutions require ownership, predictable lifespan, and eligibility for reimbursement programs. Customers can add service plans, training packages, software updates, and data-driven insights as ongoing support offerings, and certain segments can access leasing or financing structures.